Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.4.3425322
X. Bofill, P. Cole, D. Fernández-Forner
{"title":"NME Digest - April 2022","authors":"X. Bofill, P. Cole, D. Fernández-Forner","doi":"10.1358/dof.2022.47.4.3425322","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3425322","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.7.3408811
A. Akhir, A. Dasgupta, S. Chopra
{"title":"Cefepime/enmetazobactam. Beta-Lactam/beta-lactamase inhibitor, Treatment of complicated urinary tract infection","authors":"A. Akhir, A. Dasgupta, S. Chopra","doi":"10.1358/dof.2022.47.7.3408811","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3408811","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.9.3461263
L. Sorbera, C. Dulsat, A. Graul
{"title":"Therapeutic targets for dermatomyositis","authors":"L. Sorbera, C. Dulsat, A. Graul","doi":"10.1358/dof.2022.47.9.3461263","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3461263","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.8.3447439
M. Swarbrick, M. Hann, D.H. O'Donovan, M. Alavijeh, P. Jeffrey, K. Brown
{"title":"Recent Clinical Disclosures and SMR Award. Highlights from the Society for Medicines Research Conference. Virtual - December 2, 2021","authors":"M. Swarbrick, M. Hann, D.H. O'Donovan, M. Alavijeh, P. Jeffrey, K. Brown","doi":"10.1358/dof.2022.47.8.3447439","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3447439","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.11.3500032
A. Fernández-Llamazares, P. Cole, X. Bofill
{"title":"European Federation of Medicinal Chemistry - XXVII International Symposium on Medicinal Chemistry (EFMC-ISMC 2022). Nice - September 4-8, 2022","authors":"A. Fernández-Llamazares, P. Cole, X. Bofill","doi":"10.1358/dof.2022.47.11.3500032","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3500032","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.2.3393245
R. Suria, C. Vergès
The European Society of Gene and Cell Therapy (ESGCT) held its 28th annual congress in virtual format, bringing together experts and product specialists in the field of gene therapy, cell therapy and genetic vaccines.
{"title":"European Society of Gene and Cell Therapy (ESGCT) - 28th Annual Meeting. Virtual - October 19-22, 2021","authors":"R. Suria, C. Vergès","doi":"10.1358/dof.2022.47.2.3393245","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3393245","url":null,"abstract":"The European Society of Gene and Cell Therapy (ESGCT) held its 28th annual congress in virtual format, bringing together experts and product specialists in the field of gene therapy, cell therapy and genetic vaccines.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.2.3393240
J. Toldrà
{"title":"Society for Immunotherapy of Cancer (SITC) - 36th Annual Meeting. Virtual - November 10-14, 2021","authors":"J. Toldrà","doi":"10.1358/dof.2022.47.2.3393240","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3393240","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.4.3389009
J. Buxbaum
{"title":"Donanemab. Monoclonal antibody targeting N3pG beta-amyloid, Treatment of early Alzheimer's disease","authors":"J. Buxbaum","doi":"10.1358/dof.2022.47.4.3389009","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3389009","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.7.3413462
Z. Zhang, C. Gao, X. Ma, Z. Li, C. Ashby, L. Wei, Z. Chen
{"title":"Taletrectinib adipate. Dual ROS1 and NTRK inhibitor, Treatment of non-small cell lung cancer, Treatment of solid tumors","authors":"Z. Zhang, C. Gao, X. Ma, Z. Li, C. Ashby, L. Wei, Z. Chen","doi":"10.1358/dof.2022.47.7.3413462","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3413462","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.6.3373535
A. Sperry, J. Hardy, R. Goldfaden, A. Hurst, A. Ashchi, D. Sutton, M. Sheikh-Ali, J. Huston, R. Choksi
{"title":"Danuglipron. Glucagon-like peptide 1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity","authors":"A. Sperry, J. Hardy, R. Goldfaden, A. Hurst, A. Ashchi, D. Sutton, M. Sheikh-Ali, J. Huston, R. Choksi","doi":"10.1358/dof.2022.47.6.3373535","DOIUrl":"https://doi.org/10.1358/dof.2022.47.6.3373535","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：